Serum concentrations of some neuroactive steroids in women suffering from mixed anxiety-depressive disorder.
Concentrations of neurosteroids may be influenced by some physiological or pathological factors. We investigated neuroactive steroids in the serum of women suffering from anxiety-depressive disorder treated with fluoxetine and in a control group, in both the follicular and the luteal phases of the menstrual cycle. Two groups of neuroactive steroids were measured by radioimmunoassays: 1) the positive allosteric modulator of GABA(A) receptors, allopregnanolone with its precursor progesterone and 2) pregnenolone sulfate and dehydroepiandrosterone sulfate (DHEAS) acting on GABA(A) receptors by an opposite mechanism. Significantly higher levels of pregnenolone sulfate (p < 0.0001) were found in patients in both phases of the menstrual cycle. Significantly higher values were recorded in pregnenolone (p < 0.001) and 17alpha-hydroxypregnenolone (p < 0.01) levels in the patients group in the follicular phase. Our results indicate that imbalance in neuroactive steroids may play a negative role in origin and course of psychiatric and neurological disorders.
Bicíková
M
M
Institute of Endocrinology, Praha, Czech Republic. mbiciko@endo.cz
Tallová
J
J
Hill
M
M
Krausová
Z
Z
Hampl
R
R
D006907:17-alpha-Hydroxypregnenolone / Q000097:blood; D000328:Adult; D001007:Anxiety / Q000097:blood*; D003866:Depressive Disorder / Q000097:blood*; D005260:Female; D005498:Follicular Phase / Q000097:blood; D006801:Humans; D008597:Menstrual Cycle / Q000097:blood; D008875:Middle Aged; D009994:Osmolar Concentration; D011284:Pregnenolone / Q000097:blood; D013256:Steroids / Q000097:blood*
D013256:Steroids; C018370:pregnenolone sulfate; D006907:17-alpha-Hydroxypregnenolone; D011284:Pregnenolone